B
L. E. Bermudez, Petrofsky, M., and Shelton, K.,
“Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection.”,
Infection and immunity, vol. 64, no. 8, pp. 2917-22, 1996.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S.,
“Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.”,
Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.
L. E. Bermudez,
“Immunobiology of Mycobacterium avium infection.”,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13, no. 11, pp. 1000-6, 1994.
L. E. Bermudez, Wu, M., and Young, L. S.,
“Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin.”,
The Journal of infectious diseases, vol. 156, no. 3, pp. 510-3, 1987.
L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S.,
“Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”,
Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.
L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B.,
“Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.”,
The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.
L. E. Bermudez, Wu, M., and Young, L. S.,
“Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor.”,
Lymphokine research, vol. 9, no. 2, pp. 137-45, 1990.
L. E. Bermudez, Sangari, F. J., Kolonoski, P., Petrofsky, M., and Goodman, J.,
“The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells.”,
Infection and immunity, vol. 70, no. 1, pp. 140-6, 2002.
L. E. Bermudez, Wu, M., and Young, L. S.,
“Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.”,
Infection and immunity, vol. 63, no. 10, pp. 4099-104, 1995.
L. E. Bermudez, Martinelli, J., Petrofsky, M., Kolonoski, P., and Young, L. S.,
“Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.”,
The Journal of infectious diseases, vol. 169, no. 3, pp. 575-80, 1994.
L. E. Bermudez,
“[Bacteremias in immunosuppressed patients].”,
Revista paulista de medicina, vol. 104, no. 2, pp. 87-92, 1986.
L. E. Bermudez, Petrofsky, M., and Stevens, P.,
“Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.”,
Immunology, vol. 94, no. 3, pp. 297-303, 1998.
L. E. Bermudez, Nash, K. A., Petrofsky, M., Young, L. S., and Inderlied, C. B.,
“Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.”,
The Journal of infectious diseases, vol. 174, no. 6, pp. 1218-22, 1996.
L. E. Bermudez, Martinelli, J. C., Gascon, R., Wu, M., and Young, L. S.,
“Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.”,
Cytokine, vol. 2, no. 4, pp. 287-93, 1990.
L. E. Bermudez,
“Potential role of cytokines in disseminated mycobacterial infections.”,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13 Suppl 2, pp. S29-33, 1994.
L. E. Bermudez, Parker, A., and Goodman, J. R.,
“Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway.”,
Infection and immunity, vol. 65, no. 5, pp. 1916-25, 1997.
L. E. Bermudez, Wu, M., Petrofsky, M., and Young, L. S.,
“Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.”,
Infection and immunity, vol. 60, no. 10, pp. 4245-52, 1992.